IGM Biosciences Inc (IGMS) USD0.01

Sell:$1.35Buy:$1.36$0.04 (3.03%)

NASDAQ:1.02%
Market closed | Prices delayed by at least 15 minutes
Sell:$1.35
Buy:$1.36
Change:$0.04 (3.03%)
Market closed | Prices delayed by at least 15 minutes
Sell:$1.35
Buy:$1.36
Change:$0.04 (3.03%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
16 June 2025
Mary Beth HarlerHead of Division
Sell
Tax related
1,522$1.20$1,825.18338,181
16 June 2025
Misbah TahirCFO
Sell
Tax related
1,522$1.20$1,825.18178,802
16 June 2025
Lisa Lynn DeckerChief Level Officer
Sell
Tax related
951$1.20$1,140.4472,578
16 June 2025
Steven WeberOfficer
Sell
Tax related
486$1.20$582.8126,530
14 May 2025
Steven WeberOfficer
Sell
Tax related
1,865$1.12$2,089.9227,016
14 March 2025
Mary Beth HarlerHead of Division
Sell
Tax related
7,329$1.23$9,014.67339,703
14 March 2025
Misbah TahirCFO
Sell
Tax related
7,329$1.23$9,014.67180,324
14 March 2025
Lisa Lynn DeckerChief Level Officer
Sell
Tax related
4,512$1.23$5,549.7673,529
14 March 2025
Steven WeberOfficer
Sell
Tax related
1,701$1.23$2,092.2328,881
15 January 2025
Steven WeberOfficer
Sell
Tax related
1,122$1.70$1,907.2930,582

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
25 July 2024
Julie HambletonIndependent Director
Sell
Option/Award related
15,132$14.00$211,848.002,000
13 September 2024
Fred M SchwarzerPresident/CEO
Sell
Tax related
3,946$11.54$45,532.10250,124
13 September 2024
Bruce KeytChief Level Officer
Sell
Tax related
1,487$11.54$17,158.20242,948
13 September 2024
Mary Beth HarlerHead of Division
Sell
Tax related
1,487$11.54$17,158.20163,740
13 September 2024
Chris H TakimotoOther Level A
Sell
Tax related
1,487$11.54$17,158.20154,331

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.